Skip to main content

GSI 255 Pill - gray capsule/oblong, 15mm

Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide

Pill with imprint GSI 255 is Gray, Capsule/Oblong and has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc.

Odefsey is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 255

Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255

Odefsey

Generic Name
emtricitabine/rilpivirine/tenofovir alafenamide
Imprint
GSI 255
Strength
emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
Color
Gray
Size
15.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, polysorbate 20, croscarmellose sodium, magnesium stearate, water, titanium dioxide, magnesium silicate, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
61958-2101 Gilead Sciences, Inc.
54569-6645 A-S Medication Solutions, LLC (repackager)
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer